Sodium ferric gluconate complex in the treatment ofiron deficiency for patients on dialysis
- 31 May 2001
- journal article
- review article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 37 (5), 879-883
- https://doi.org/10.1016/s0272-6386(05)80001-0
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Percentage of hypochromic red blood cells as predictor of erythropoietic and iron response after i.v. iron supplementation in maintenance haemodialysis patientsNephrology Dialysis Transplantation, 1997
- Iron management in end-stage renal diseaseAmerican Journal of Kidney Diseases, 1997
- The safety of intravenous iron dextran in hemodialysis patientsAmerican Journal of Kidney Diseases, 1996
- Regular low-dose intravenous iron therapy improves response to erythropoietin in haemodialysis patientsNephrology Dialysis Transplantation, 1996
- 'Oversaturation' of transferrin after intravenous ferric gluconate (FerrlecitR) in haemodialysis patientsNephrology Dialysis Transplantation, 1996
- Economic appraisal of maintenance parenteral iron administration in treatment of anaemia in chronic haemodialysis patientsNephrology Dialysis Transplantation, 1996
- Intravenous Ferric Saccharate as an Iron Supplement in Dialysis PatientsNephron, 1996
- Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementationAmerican Journal of Kidney Diseases, 1995
- Intravenous Fe-Gluconate-Na for Iron-Deficient Patients on HemodialysisNephron, 1992
- Iron Deficiency in Maintenance Hemodialysis Patients: Assessment of Diagnosis Criteria and of Three Different Iron TreatmentsNephron, 1991